Law360 interviewed Ira A. Rosenberg, Co-Chair of the Firm’s Corporate Department and Chair of the Firm’s Life Sciences Practice. Mr. Rosenberg discusses his most challenging deal, regulation in need of reform and advice to aspiring dealmakers, among other topics.
